Evaluation of Hepatic Arterial Infusion of Cisplatin and 5-FU in Biomarker Stratified HCC
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
This study is to assess the efficacy and the safety of hepatic arterial infusion of cisplatin
and 5-fluorouracil (HAIC) in advanced HCC patients stratified by biomarker expression
predicting therapeutic response.